These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24858403)

  • 1. Determination of small molecule ABAD inhibitors crossing blood-brain barrier and pharmacokinetics.
    Vangavaragu JR; Valasani KR; Fang D; Williams TD; Yan SS
    J Alzheimers Dis; 2014; 42(1):333-44. PubMed ID: 24858403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and in vitro evaluation of benzothiazole-based ureas as potential ABAD/17β-HSD10 modulators for Alzheimer's disease treatment.
    Hroch L; Benek O; Guest P; Aitken L; Soukup O; Janockova J; Musil K; Dohnal V; Dolezal R; Kuca K; Smith TK; Gunn-Moore F; Musilek K
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3675-8. PubMed ID: 27287370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of human ABAD inhibitors for rescuing Aβ-mediated mitochondrial dysfunction.
    Valaasani KR; Sun Q; Hu G; Li J; Du F; Guo Y; Carlson EA; Gan X; Yan SS
    Curr Alzheimer Res; 2014 Feb; 11(2):128-36. PubMed ID: 24479630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer's disease treatment.
    Hroch L; Guest P; Benek O; Soukup O; Janockova J; Dolezal R; Kuca K; Aitken L; Smith TK; Gunn-Moore F; Zala D; Ramsay RR; Musilek K
    Bioorg Med Chem; 2017 Feb; 25(3):1143-1152. PubMed ID: 28082069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Assay Development and HTS of Small-Molecule Human ABAD/17β-HSD10 Inhibitors as Therapeutics in Alzheimer's Disease.
    Aitken L; Baillie G; Pannifer A; Morrison A; Jones PS; Smith TK; McElroy SP; Gunn-Moore FJ
    SLAS Discov; 2017 Jul; 22(6):676-685. PubMed ID: 28314118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease.
    Morsy A; Trippier PC
    J Med Chem; 2019 May; 62(9):4252-4264. PubMed ID: 30444369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease.
    Yao J; Du H; Yan S; Fang F; Wang C; Lue LF; Guo L; Chen D; Stern DM; Gunn Moore FJ; Xi Chen J; Arancio O; Yan SS
    J Neurosci; 2011 Feb; 31(6):2313-20. PubMed ID: 21307267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design and synthesis of benzothiazole phosphonate analogues with inhibitors of human ABAD-Aβ for treatment of Alzheimer's disease.
    Valasani KR; Hu G; Chaney MO; Yan SS
    Chem Biol Drug Des; 2013 Feb; 81(2):238-49. PubMed ID: 23039767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of sodium tanshinone II A sulfonate tissue distribution in rat by liquid chromatography/tandem mass spectrometry.
    He T; Zou Q; Feng Z; Zhang Z
    Arzneimittelforschung; 2010; 60(11):660-6. PubMed ID: 21175038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABAD: a potential therapeutic target for Abeta-induced mitochondrial dysfunction in Alzheimer's disease.
    Marques AT; Fernandes PA; Ramos MJ
    Mini Rev Med Chem; 2009 Jul; 9(8):1002-8. PubMed ID: 19601895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of human ABAD/HSD10 with a bound inhibitor: implications for design of Alzheimer's disease therapeutics.
    Kissinger CR; Rejto PA; Pelletier LA; Thomson JA; Showalter RE; Abreo MA; Agree CS; Margosiak S; Meng JJ; Aust RM; Vanderpool D; Li B; Tempczyk-Russell A; Villafranca JE
    J Mol Biol; 2004 Sep; 342(3):943-52. PubMed ID: 15342248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an UPLC-MS/MS method for quantification of Avitinib (AC0010) and its five metabolites in human cerebrospinal fluid: Application to a study of the blood-brain barrier penetration rate of non-small cell lung cancer patients.
    Wang W; Zheng X; Wang H; Wang L; Jiang J; Hu P
    J Pharm Biomed Anal; 2017 May; 139():205-214. PubMed ID: 28285073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of a novel carbamate AChE inhibitor meserine in mouse plasma, brain and rat plasma by LC-MS/MS: application to pharmacokinetic study after intravenous and subcutaneous administration.
    Xie Y; Jiang P; Ge X; Wang H; Shao B; Xie Q; Qiu Z; Chen H
    J Pharm Biomed Anal; 2014 Aug; 96():156-61. PubMed ID: 24747147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-(Benzo[d]thiazol-2-yl)-3-phenylureas as dual inhibitors of casein kinase 1 and ABAD enzymes for treatment of neurodegenerative disorders.
    Benek O; Hroch L; Aitken L; Gunn-Moore F; Vinklarova L; Kuca K; Perez DI; Perez C; Martinez A; Fisar Z; Musilek K
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):665-670. PubMed ID: 29536773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer's Disease Mouse Model.
    Zakaria A; Hamdi N; Abdel-Kader RM
    Mol Neurobiol; 2016 Mar; 53(2):1220-1228. PubMed ID: 25601181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrine - Benzothiazoles: Novel class of potential multitarget anti-Alzheimeŕs drugs dealing with cholinergic, amyloid and mitochondrial systems.
    Nepovimova E; Svobodova L; Dolezal R; Hepnarova V; Junova L; Jun D; Korabecny J; Kucera T; Gazova Z; Motykova K; Kubackova J; Bednarikova Z; Janockova J; Jesus C; Cortes L; Pina J; Rostohar D; Serpa C; Soukup O; Aitken L; Hughes RE; Musilek K; Muckova L; Jost P; Chvojkova M; Vales K; Valis M; Chrienova Z; Chalupova K; Kuca K
    Bioorg Chem; 2021 Feb; 107():104596. PubMed ID: 33421953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An LC/MS quantitative and microdialysis method for cyclovirobuxine D pharmacokinetics in rat plasma and brain: The pharmacokinetic comparison of three different drug delivery routes.
    Wei JB; Lai Q; Shumyak SP; Xu LF; Zhang CX; Ling JJ; Yu Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():185-93. PubMed ID: 26342162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative determination of β-hydroxymethylbutyrate and leucine in culture media and microdialysates from rat brain by UHPLC-tandem mass spectrometry.
    Santos-Fandila A; Zafra-Gómez A; Barranco A; Navalón A; Rueda R; Ramírez M
    Anal Bioanal Chem; 2014 May; 406(12):2863-72. PubMed ID: 24590106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of small-molecule inhibitors of the Abeta-ABAD interaction.
    Xie Y; Deng S; Chen Z; Yan S; Landry DW
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4657-60. PubMed ID: 16781151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies.
    Chen J; Wu H; Xu GB; Dai MM; Hu SL; Sun LL; Wang W; Wang R; Li SP; Li GQ
    J Pharm Biomed Anal; 2015 Apr; 108():122-8. PubMed ID: 25771205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.